Status and phase
Conditions
Treatments
About
PRIMARY OBJECTIVES:
Determination of safety and toxicity of vaccination with mRNA transfected DC (based on blood samples, and adverse events).
SECONDARY OBJECTIVES:
Determine immunological response to the vaccine (induction of specific T-cell response) and assessment of tumour response.
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal